Cargando…
Prevention of therapy-related malignances in cancer survivors
Autores principales: | Belitsky, Gennady A., Kirsanov, Kirill I., Lesovaya, Ekaterina A., Yakubovskaya, Marianna G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481337/ https://www.ncbi.nlm.nih.gov/pubmed/31040903 http://dx.doi.org/10.18632/oncotarget.26781 |
Ejemplares similares
-
Current Approaches for Personalized Therapy of Soft Tissue Sarcomas
por: Kirsanov, Kirill I., et al.
Publicado: (2020) -
A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
por: Zhidkova, Ekaterina M, et al.
Publicado: (2020) -
Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
por: Zhidkova, Ekaterina M., et al.
Publicado: (2022) -
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo
por: Fetisov, Timur I., et al.
Publicado: (2023) -
HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes
por: Maksimova, Varvara, et al.
Publicado: (2021)